ElanIce Gel
Natural health product licensed in Canada
- Licence holder
- Elan Healthcare Inc.
- NPN or DIN-HM
- 80136966
- Status
- Active licence
- Licence date
- 10 December 2024
- Revision date
- Not provided
- Form
- Gel
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| l-Menthol Source : l-Menthol | 4 % |
Non-medicinal ingredients
Extrait de résine de Boswellia Carterii, Laque d'aluminium jaune FD&C No. 5, Laque d'aluminium bleu FD&C n° 1, Glycérine, Acétate de dl-alpha tocophéryle, Extrait de Feuilles d'Ilex paraguariensis, Aqua, Myristate d'isopropyle, dl-Camphre, Triéthanolamine, Extrait de racine d'Arctium Lappa, Extrait floral de Calendula Officinalis, Silice pyrogénée, Extrait de feuilles d'Aloe barbadensis, Carbomère U-10, Extrait de feuille de Melissa officinalis, Alcool isopropylique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | Not specified | Not specified |
| Enfants | minimum: 2 years ; maximum: 11 years | Not specified | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Temporarily relieves aches and pains/soreness of muscles and joints (associated with one or more of the following: simple backache, lumbago, strains and sprains (involving muscles, tendons, and/or ligaments), and arthritis).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80136966
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.